Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.92% | -2.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.92% | -2.70% | |||
| Cost of Revenue | 9.33% | -10.19% | |||
| Gross Profit | 13.46% | -1.49% | |||
| SG&A Expenses | -1.49% | 3.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.05% | 1.03% | |||
| Operating Income | 102.84% | -23.97% | |||
| Income Before Tax | 71.84% | -24.94% | |||
| Income Tax Expenses | 324.41% | -188.99% | |||
| Earnings from Continuing Operations | 8.11% | 6.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -9.94% | 31.63% | |||
| Net Income | 8.10% | 7.08% | |||
| EBIT | 102.84% | -23.97% | |||
| EBITDA | 67.42% | -16.25% | |||
| EPS Basic | 8.28% | 7.39% | |||
| Normalized Basic EPS | 72.69% | -12.56% | |||
| EPS Diluted | 7.40% | 6.69% | |||
| Normalized Diluted EPS | 72.99% | -12.75% | |||
| Average Basic Shares Outstanding | -0.17% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.34% | -0.06% | |||
| Dividend Per Share | 0.00% | 9.09% | |||
| Payout Ratio | 0.01% | -0.07% | |||